Close

TCR² Therapeutics Presents Preclinical Data on IL-15 Enhanced TRuCs at AACR Virtual Special Conference on Tumor Immunology & Immunotherapy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. IBM
4. HCP
5. ALGN
6. BIIB
7. BHP
8. F
9. PI
10. BSX


Go back to TCR² Therapeutics Presents Preclinical Data on IL-15 Enhanced TRuCs at AACR Virtual Special Conference on Tumor Immunology & Immunotherapy
(NASDAQ: TCRR) Delayed: 1.48 --0 (-0%)
Previous Close $1.48    52 Week High $ 
Open $1.48    52 Week Low $ 
Day High $1.48    P/E N/A 
Day Low $1.48    EPS $ 
Volume 400